5 completed. 5 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow Synflorix: new trials by email Literature Review of Synflorix trials Research Report on Synflorix
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Respiratory Syncytial Virus (RSV) Investigational Vaccine in Infants Aged 6 and 7 Months Likely to be Unexposed to RSV RSV (GSK3389245A) lower dose formulation vaccine, RSV (GSK3389245A) higher dose formulation vaccine, GSK's multicomponent meningococcal B vaccine - Respiratory Syncytial Virus Infections | Phase 1 / Phase 2 | Completed | GlaxoSmithKline | 201 | 2019-04-08 | 2022-07-27 |
| Dose-Finding Study of S.Pneumoniae Whole Cell Vaccine Adsorbed to Alum (PATH-wSP) in Healthy Kenyan Adults and Toddlers PATH-wSP, Synflorix, Pentavac - Pneumonia, Pneumococcal | Phase 1 / Phase 2 | Completed | PATH | 304 | 2014-04-01 | 2019-10-10 |
| Trial of Pneumococcal Vaccine Schedules in Ho Chi Minh City, Vietnam PCV10, PCV13 - Pneumococcal Vaccines | Phase 2 / Phase 3 | Completed | Murdoch Childrens Research Institute | 1400 | 2013-09-30 | 2022-09-14 |
| Safety & Immunogenicity of Pneumococcal Vaccine 2189242A Co-administered With DTPa-HBV-IPV/Hib in Healthy Infants Pneumococcal vaccine GSK 2189242A (LD formulation 1), Pneumococcal vaccine GSK 2189242A (HD formulation 2), Synflorix - Infections, Streptococcal | Phase 2 | Completed | GlaxoSmithKline | 576 | 2010-09-27 | 2019-05-29 |
| Assess Reacto- and Immunogenicity of Pneumococcal Conjugate Vaccine When Given as Booster or a 2 Dose Catch up Schedule Synflorix, Infanrix Hexa, Havrix - Infections, Streptococcal | Phase 2 | Completed | GlaxoSmithKline | 163 | 2007-08-22 | 2018-12-19 |
Streptococcal Infections (2) · Haemophilus Infections (1) · Pneumococcal Infections (1) · Pneumonia, Pneumococcal (1) · Respiratory Syncytial Virus Infections (1)
GlaxoSmithKline (3) · Murdoch Childrens Research Institute (1) · PATH (1)
Poland (2) · Brazil (1) · Canada (1) · Chile (1) · Colombia (1) · Czechia (1) · Finland (1) · Germany (1) · Italy (1) · Kenya (1) · Mexico (1) · Panama (1) · Spain (1) · Sweden (1) · Thailand (1)
Edward K Mulholland, MBBS, FRACP (1) · Nekoye Otsyula, MD (1)
PMID 29884695, PMID 30975525, PMID 33745731, PMID 34171233, PMID 36785850, PMID 37477875, PMID 41442837
2018 (1)